ReviewFrontiers in neurology
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.
Pietro Annovazzi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
pooled itcites it